We are live on !
Find out more
Smithbridge Asset Management Portfolio holdings
AUM
$741M
Turnover
6.7%
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+22.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$741M
AUM Growth
+$7.12M
(+0.97%)
Cap. Flow
+$18.6M
Cap. Flow % of AUM
Cap. Flow %
2.51%
Top 10 Holdings %
Top 10 Hldgs %
33.29%
Holding
194
New
6
Increased
58
Reduced
74
Closed
7
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.5
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$6.39M |
| 2 |
Danaher
DHR
|
+$5.71M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$2.4M |
| 4 |
Vanguard Core Bond ETF
VCRB
|
+$1.67M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$3.89M |
| 2 |
Honeywell
HON
|
+$3.63M |
| 3 |
Unilever
UL
|
+$3.32M |
| 4 |
Applied Materials
AMAT
|
+$1.04M |
| 5 |
Zoetis
ZTS
|
+$874K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 35.85% |
| 2 | Technology | 22.93% |
| 3 | Healthcare | 9.54% |
| 4 | Industrials | 9.44% |
| 5 | Financials | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
TJX Companies
TJX
$150B
| $8.82M | 1.19% |
66,678
-838
| -1% | -$121K |
2013 Q2
53 quarters
|
|
|
27
Danaher
DHR
$163B
| $8.73M | 1.18% |
39,387
+27,808
| +240% | +$5.71M |
2026 Q2
1 quarter
|
|
|
28
iShares Core S&P 500 ETF
IVV
$878B
| $8.11M | 1.09% |
10,592
+8,376
| +378% | +$6.39M |
2021 Q2
21 quarters
|
|
29
AbbVie
ABBV
$520B
| $8.04M | 1.09% |
30,750
+1,535
| +5% | +$394K |
2013 Q2
53 quarters
|
|
30
Palo Alto Networks
PANW
$264B
| $7.83M | 1.06% |
19,714
-292
| -1% | -$104K |
2023 Q2
13 quarters
|
|
31
Advanced Micro Devices
AMD
$960B
| $7.73M | 1.04% |
12,628
+1,099
| +10% | +$565K |
2026 Q1
2 quarters
|
|
32
Arthur J. Gallagher & Co
AJG
$71.1B
| $7.43M | 1% |
32,561
-101
| -0.3% | -$25.3K |
2019 Q2
29 quarters
|
|
33
Apollo Global Management
APO
$71.6B
| $7.41M | 1% |
63,824
-474
| -0.7% | -$60.2K |
2023 Q3
12 quarters
|
|
|
34
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $7.02M | 0.95% |
99,457
+21,340
| +27% | +$1.53M |
2017 Q2
37 quarters
|
|
35
Novartis
NVS
$303B
| $6.94M | 0.94% |
48,698
-435
| -0.9% | -$66K |
2017 Q2
37 quarters
|
|
36
Lockheed Martin
LMT
$140B
| $6.59M | 0.89% |
12,934
-37
| -0.3% | -$20.3K |
2016 Q1
42 quarters
|
|
37
Eli Lilly
LLY
$1.27T
| $6.58M | 0.89% |
5,689
-194
| -3% | -$229K |
2022 Q4
15 quarters
|
|
38
United Rentals
URI
$70.5B
| $6.39M | 0.86% |
6,389
-192
| -3% | -$205K |
2022 Q4
15 quarters
|
|
39
Ecolab
ECL
$85.4B
| $5.57M | 0.75% |
20,295
-85
| -0.4% | -$23.6K |
2013 Q2
53 quarters
|
|
40
Procter & Gamble
PG
$389B
| $5.44M | 0.73% |
37,479
-512
| -1% | -$75K |
2013 Q2
53 quarters
|
|
41
Medtronic
MDT
$129B
| $5.36M | 0.72% |
62,097
+1,867
| +3% | +$165K |
2013 Q2
53 quarters
|
|
42
Accenture
ACN
$148B
| $5.1M | 0.69% |
27,813
+733
| +3% | +$124K |
2013 Q2
53 quarters
|
|
43
Rockwell Automation
ROK
$44.9B
| $4.92M | 0.66% |
11,308
-84
| -0.7% | -$37.4K |
2021 Q3
20 quarters
|
|
44
Stryker
SYK
$119B
| $4.87M | 0.66% |
17,696
-155
| -0.9% | -$48.8K |
2013 Q2
53 quarters
|
|
45
Abbott
ABT
$186B
| $4.8M | 0.65% |
48,595
+2,901
| +6% | +$303K |
2013 Q2
53 quarters
|
|
46
JPMorgan Ultra-Short Income ETF
JPST
$42.5B
| $4.75M | 0.64% |
94,280
+6,297
| +7% | +$318K |
2025 Q3
4 quarters
|
|
47
iShares MSCI Emerging Markets ex China ETF
EMXC
$25.5B
| $4.09M | 0.55% |
41,259
+48
| +0.1% | +$4.65K |
2025 Q1
6 quarters
|
|
48
Novo Nordisk
NVO
$179B
| $4.02M | 0.54% |
106,090
+4,021
| +4% | +$185K |
2013 Q2
53 quarters
|
|
49
Deere & Co
DE
$183B
| $4.02M | 0.54% |
5,980
+425
| +8% | +$270K |
2025 Q4
3 quarters
|
|
50
iShares Core MSCI Emerging Markets ETF
IEMG
$146B
| $3.83M | 0.52% |
47,193
-1,396
| -3% | -$112K |
2025 Q1
6 quarters
|
|
Similar funds
BFCFSI
Smithbridge Asset Management's Q3 2026 Portfolio in Review
As of Q3 2026, Smithbridge Asset Management held 194 positions worth $741M, up 0.97% from $734M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Smithbridge Asset Management's Q3 2026 filing shows 6 new, 58 increased, 74 reduced and 7 closed positions. Its largest new stake was ExxonMobil: 6,250 shares worth $1.02M. The largest sale was Labcorp, an estimated $3.89M.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, up from 35% a quarter earlier, followed by Technology and Healthcare.
- Smithbridge Asset Management's largest Q3 2026 buy was ExxonMobil: 6,250 shares worth $1.02M.
- Smithbridge Asset Management added most to iShares Core S&P 500 ETF in Q3 2026, an estimated $6.39M increase.
- Smithbridge Asset Management's biggest Q3 2026 reduction was Labcorp, cutting an estimated $3.89M.
- Smithbridge Asset Management fully exited Honeywell in Q3 2026, selling an estimated $3.63M.
- Smithbridge Asset Management's ten largest holdings make up 33% of its $741M portfolio in Q3 2026.
- Smithbridge Asset Management opened 6 new positions and closed 7 in Q3 2026.
- Smithbridge Asset Management's portfolio value rose 0.97% quarter-over-quarter to $741M.
Based on Smithbridge Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.